Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus

Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus

US Patent 8034802 · Granted Oct 11, 2011

Estimated economic value: $853,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reduction of infections in healthcare settings using photocatalytic compositions2019
Titanium dioxide photocatalytic compositions and uses thereof2017
Titanium dioxide photocatalytic compositions and uses thereof2016
Titanium dioxide photocatalytic compositions and uses thereof2016
Titanium dioxide photocatalytic compositions and uses thereof2015
Titanium dioxide photocatalytic compositions and uses thereof2015
Titanium dioxide photocatalytic compositions and uses thereof2013
Administration of TLR7 ligands and prodrugs thereof for treatment of infection b2012
3-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereof2011
Administration of TLR7 ligands and prodrugs thereof for treatment of infection b2010
3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof2010
Administration of TLR7 ligands and prodrugs thereof for treatment of infection b2009